Alaunos Therapeutics Files 2024 10-K

Ticker: TCRT · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1107421

Alaunos Therapeutics, INC. 10-K Filing Summary
FieldDetail
CompanyAlaunos Therapeutics, INC. (TCRT)
Form Type10-K
Filed DateMar 31, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

Alaunos (TCAP) filed its 2024 10-K. Full financials and ops update.

AI Summary

Alaunos Therapeutics, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as ZIOPHARM ONCOLOGY INC, is focused on pharmaceutical preparations. Key financial data and operational details from the past fiscal year are presented in this comprehensive filing.

Why It Matters

This filing provides investors and stakeholders with a detailed overview of Alaunos Therapeutics' financial health, operational performance, and strategic direction for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Alaunos Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What was Alaunos Therapeutics' former company name?

Alaunos Therapeutics, Inc. was formerly known as ZIOPHARM ONCOLOGY INC.

What is the Standard Industrial Classification code for Alaunos Therapeutics?

The SIC code for Alaunos Therapeutics is 2834, which corresponds to Pharmaceutical Preparations.

On what date was this 10-K filing submitted?

This 10-K filing was submitted on March 31, 2025.

What fiscal year does this 10-K report cover?

This 10-K report covers the fiscal year ending December 31, 2024.

In which state was Alaunos Therapeutics incorporated?

Alaunos Therapeutics, Inc. was incorporated in Delaware (DE).

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Alaunos Therapeutics, Inc. (TCRT).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing